Pazopanib Tablet, Film Coated
Product Images NDC 42291-939

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pazopanib (NDC 42291-939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120 (939 12)

Label for Pazopanib Tablets 200 mg film-coated oral tablets by AvKARE. The label indicates 120 tablets per bottle, prescription only. It includes dosing instructions to dispense the accompanying medication guide with each prescription and storage conditions. The label also displays the AvKARE logo, a QR code, and packaging and manufacturer details.*

FDA Label Image

New (Pazopanib Tablets 200 mg A217517 1)

Chemical structure of Pazopanib, a molecular diagram showing its chemical bonds and atoms, including notable methyl groups, nitrogen atoms, and a sulfonamide group with hydrochloride indicated.*

FDA Label Image

1 (Pazopanib Tablets 200 mg A217517 2)

A Kaplan-Meier curve showing the proportion of patients progression-free over time (months) comparing Pazopanib versus placebo. The plot includes median progression-free survival times, hazard ratio, confidence interval, and p-value, illustrating a longer progression-free duration for Pazopanib-treated patients.*

FDA Label Image

22 (Pazopanib Tablets 200 mg A217517 3)

A Kaplan-Meier survival curve showing the proportion progression-free over time (months) comparing Pazopanib treatment (N=246) with placebo (N=123). The curve illustrates median progression-free survival of 4.6 months for Pazopanib and 1.6 months for placebo, with statistical data including hazard ratio and confidence interval noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.